Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

ClinicalTrials.gov ID: NCT02528721

Public ClinicalTrials.gov record NCT02528721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the BreathID® Hp Lab System Compared to Biopsy Results

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Exalenz Dual Mode BreathID® Hp System comprised of IDkit: Hp™ TWO and the Dual Mode BreathID® Hp test device will be used to perform a urea breath test in the initial diagnosis and post treatment monitoring of H.pylori infection in adult patients and its results will be compared to biopsy results.

Study identification

NCT ID
NCT02528721
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Meridian Bioscience, Inc.
Industry
Enrollment
282 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Type not available)
Primary completion
Jun 2016 (Actual)
Completion
Jul 2016 (Actual)
Last update posted
Dec 20, 2022

2015 – 2016

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Del Sol Research Management Tucson Arizona 85710 —
Ventura Clinical Trials Ventura California 93003 —
Innovative Clincal Research Lafayette Colorado 80026 —
Palmetto Research Hialeah Florida 33016 —
Hope Clinical Research Kissimmee Florida 34741 —
Metropolitan Gastro Group Chevy Chase Maryland 20815 —
Gasrtrenetrology Associates of Western Michigan, West Michigan Clinical Research Center Wyoming Michigan 49519 —
Digestive Disease Care New Hyde Park New York 11040 —
Great Lakes Medical Research Willoughby Ohio 44094 —
Innovative Clinical Research Rapid City South Dakota 57701 —
Digestive Disease Center of South Texas, P.L.L.C San Antonio Texas 78215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02528721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02528721 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →